Every record from Medutest · page 6
Fast turnaround and the widest compound acceptance, at unit mass resolution rather than high resolution. Measured offset against the reference laboratory is +0.065 pp on 517 paired lots. Full laboratory profile →
| Report | Compound | Supplier | Lot | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-042677 | Retatrutide | GGPeps | GGPE-2510-R9180 | 2026-Q1 | 99.45 | 3.45 | 92.1 | Laboratory-retained | 1 | MARGINAL |
| AX-2026-042411 | CJC-1295 (no DAC) | SWB | SWB-2512-S5560 | 2026-Q1 | 98.76 | 3.89 | — | Buyer-sourced | 1 | MARGINAL |
| AX-2026-041549 | TB-500 | QYB | QYB-2511-H6699 | 2026-Q1 | 99.38 | 5.63 | — | Supplier-supplied | 2 | MARGINAL |
| AX-2026-041409 | PT-141 (Bremelanotide) | WWB | WWB-2509-A4716 | 2026-Q1 | 99.90 | 4.83 | 95.5 | Supplier-supplied | 0 | PASS |
| AX-2026-042404 | Semaglutide | SWB | SWB-2512-L5147 | 2026-Q1 | 97.25 | 5.02 | — | Buyer-sourced | 1 | MARGINAL |
| AX-2026-043158 | Retatrutide | SSA | SSA-2601-T7702 | 2026-Q1 | 98.96 | 5.07 | 96.2 | Supplier-supplied | 2 | MARGINAL |
| AX-2026-041509 | Enclomiphene citrate | QYB | QYB-2603-A6476 | 2026-Q1 | 99.93 | 4.69 | 102.8 | Laboratory-retained | 0 | FAIL |
| AX-2026-041915 | L-Glutathione (reduced) | JEEP | JEEP-2510-S3920 | 2026-Q1 | 99.08 | 7.80 | — | Laboratory-retained | 0 | PASS |
| AX-2026-041637 | Semaglutide | QSC | QSC-2602-L8571 | 2026-Q1 | 99.41 | 4.44 | 100.5 | Supplier-supplied | 2 | MARGINAL |
| AX-2026-041419 | GHRP-2 | WWB | WWB-2511-K4194 | 2026-Q1 | 99.69 | 4.13 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2026-042197 | Semaglutide | Homopeptide | HOMO-2511-C9607 | 2026-Q1 | 98.80 | 4.65 | — | Laboratory-retained | 1 | MARGINAL |
| AX-2026-041872 | CJC-1295 with DAC | JEEP | JEEP-2601-V2811 | 2026-Q1 | 98.56 | 4.34 | — | Laboratory-retained | 1 | MARGINAL |
| AX-2026-041341 | CJC-1295 with DAC | WWB | WWB-2508-V3100 | 2026-Q1 | 99.93 | 6.30 | — | Supplier-supplied | 0 | PASS |
| AX-2026-042379 | Tirzepatide | SWB | SWB-2601-V4383 | 2026-Q1 | 98.64 | 4.35 | 88.7 | Supplier-supplied | 3 | MARGINAL |
| AX-2026-041582 | CJC-1295 with DAC | QSC | QSC-2512-G6894 | 2026-Q1 | 99.29 | 2.85 | 98.4 | Supplier-supplied | 1 | MARGINAL |
| AX-2026-043263 | Selank | SGN | SGN-2508-Y1438 | 2026-Q1 | 98.06 | 5.62 | 97.7 | Buyer-sourced | 0 | FAIL |
| AX-2026-042417 | Semaglutide | SWB | SWB-2602-W5529 | 2026-Q1 | 99.93 | 6.09 | 94.9 | Supplier-supplied | 1 | MARGINAL |
| AX-2026-041469 | Humanin (HNG) | QYB | QYB-2512-A5720 | 2026-Q1 | 99.64 | 4.70 | 97.2 | Supplier-supplied | 2 | FAIL |
| AX-2026-043485 | BPC-157 | WXT | WXT-2602-P5658 | 2026-Q1 | 99.15 | 2.05 | 106.4 | Supplier-supplied | 2 | MARGINAL |
| AX-2026-041965 | KPV | TFC | TFC-2508-M4888 | 2026-Q1 | 99.93 | 2.66 | 105.0 | Supplier-supplied | 0 | FAIL |
| AX-2026-041894 | BPC-157 | JEEP | JEEP-2509-G3860 | 2026-Q1 | 99.17 | 3.68 | 91.0 | Supplier-supplied | 1 | MARGINAL |
| AX-2026-043477 | BPC-157 | WXT | WXT-2602-P5658 | 2026-Q1 | 98.21 | 1.52 | 98.1 | Buyer-sourced | 2 | MARGINAL |
| AX-2026-042263 | Dihexa | Homopeptide | HOMO-2509-M1537 | 2026-Q1 | 99.58 | 6.75 | — | Supplier-supplied | 2 | MARGINAL |
| AX-2026-042081 | BPC-157 | TFC | TFC-2512-L7022 | 2026-Q1 | 98.74 | 6.39 | 105.5 | Supplier-supplied | 2 | MARGINAL |
| AX-2026-043071 | Epitalon | KP | KP-2508-Y5329 | 2026-Q1 | 98.25 | 8.64 | 92.3 | Supplier-supplied | 0 | FAIL |
| AX-2026-042923 | Semaglutide | MKM | MKM-2508-R2718 | 2026-Q1 | 99.22 | 5.33 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2026-042615 | Semax | GGPeps | GGPE-2511-X8435 | 2026-Q1 | 98.19 | 6.60 | — | Supplier-supplied | 1 | FAIL |
| AX-2026-042908 | Adipotide | MKM | MKM-2511-F2657 | 2026-Q1 | 98.59 | 5.61 | 96.9 | Supplier-supplied | 0 | PASS |
| AX-2026-041823 | Retatrutide | FGP | FGP-2512-V2097 | 2026-Q1 | 98.27 | 5.33 | 93.9 | Supplier-supplied | 2 | FAIL |
| AX-2026-042503 | Humanin (HNG) | ERP | ERP-2601-P6603 | 2026-Q1 | 98.77 | 3.55 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2026-042838 | CJC-1295 with DAC | GGPeps | GGPE-2510-T1661 | 2026-Q1 | 97.96 | 5.62 | — | Supplier-supplied | 3 | FAIL |
| AX-2026-042751 | ARA-290 | GGPeps | GGPE-2602-W9566 | 2026-Q1 | 98.86 | 2.17 | 93.9 | Supplier-supplied | 1 | MARGINAL |
| AX-2026-043366 | Ipamorelin | CPC | CPC-2508-Y2949 | 2026-Q1 | 98.82 | 5.09 | 91.6 | Supplier-supplied | 1 | FAIL |
| AX-2026-041835 | Semax | JEEP | JEEP-2602-C3015 | 2026-Q1 | 99.08 | 8.04 | — | Supplier-supplied | 0 | PASS |
| AX-2026-041673 | Ipamorelin | QSC | QSC-2602-W8804 | 2026-Q1 | 99.93 | 6.00 | — | Supplier-supplied | 2 | MARGINAL |
| AX-2026-042146 | Leuprolide | Homopeptide | HOMO-2508-N8842 | 2026-Q1 | 99.93 | 4.91 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2026-041903 | TB-500 | JEEP | JEEP-2510-R4058 | 2026-Q1 | 99.82 | 4.71 | 106.1 | Supplier-supplied | 1 | MARGINAL |
| AX-2026-043309 | L-Glutathione (reduced) | CPC | CPC-2602-D2535 | 2026-Q1 | 98.93 | 8.32 | — | Supplier-supplied | 0 | PASS |
| AX-2026-041918 | L-Glutathione (reduced) | JEEP | JEEP-2510-S3920 | 2026-Q1 | 99.65 | 7.47 | 103.2 | Laboratory-retained | 0 | PASS |
| AX-2026-041688 | Semaglutide | QSC | QSC-2508-F9226 | 2026-Q1 | 99.74 | 4.73 | — | Supplier-supplied | 2 | MARGINAL |